PureTech
VS
Scribe Therapeutics

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

P
PureTech

PureTech Health is a publicly traded biopharmaceutical company that discovers, develops, and commercializes breakthrough medicines by founding and funding a network of subsidiary companies, including Celea Therapeutics.

2 Pulse stories
ST
Scribe Therapeutics

Clinical-stage biotech developing CRISPR-based gene-editing therapeutics using its proprietary CasX enzyme platform.

5 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2005
Founded
2018
Boston, Massachusetts
HQ
Alameda, California
Public (PRTC)
Status
Public (SCTX)
PureTech investors
No investors on record.
Scribe Therapeutics investors
No investors on record.

Data from Value Add Pulse coverage and company research — see the full threads for PureTech and Scribe Therapeutics.